» Articles » PMID: 20877571

Light Chain Separated from the Rest of the Type a Botulinum Neurotoxin Molecule is the Most Catalytically Active Form

Overview
Journal PLoS One
Date 2010 Sep 30
PMID 20877571
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Botulinum neurotoxins (BoNT) are the most potent of all toxins. The 50 kDa N-terminal endopeptidase catalytic light chain (LC) of BoNT is located next to its central, putative translocation domain. After binding to the peripheral neurons, the central domain of BoNT helps the LC translocate into cytosol where its proteolytic action on SNARE (soluble NSF attachment protein receptor) proteins blocks exocytosis of acetyl choline leading to muscle paralysis and eventual death. The translocation domain also contains 105 Å -long stretch of ∼100 residues, known as "belt," that crosses over and wraps around the LC to shield the active site from solvent. It is not known if the LC gets dissociated from the rest of the molecule in the cytosol before catalysis. To investigate the structural identity of the protease, we prepared four variants of type A BoNT (BoNT/A) LC, and compared their catalytic parameters with those of BoNT/A whole toxin. The four variants were LC + translocation domain, a trypsin-nicked LC + translocation domain, LC + belt, and a free LC. Our results showed that K(m) for a 17-residue SNAP-25 (synaptosomal associated protein of 25 kDa) peptide for these constructs was not very different, but the turnover number (k(cat)) for the free LC was 6-100-fold higher than those of its four variants. Moreover, none of the four variants of the LC was prone to autocatalysis. Our results clearly demonstrated that in vitro, the LC minus the rest of the molecule is the most catalytically active form. The results may have implication as to the identity of the active, toxic moiety of BoNT/A in vivo.

Citing Articles

Detection of botulinum neurotoxin A (BoNT/A) enzymatic activity by pregnancy test strips based on hCG-modified magnetic nanoparticles.

Zhou X, Qi M, Yang M Mikrochim Acta. 2024; 191(2):114.

PMID: 38286853 DOI: 10.1007/s00604-024-06197-4.


Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?.

Dicks L, Vermeulen W Microorganisms. 2022; 10(9).

PMID: 36144335 PMC: 9501580. DOI: 10.3390/microorganisms10091733.


Expression and purification of recombinant TAT-BoNT/A under denaturing and native conditions.

Saffarian P, Najar Peerayeh S, Amani J, Ebrahimi F, Sedighianrad H, Halabian R Bioengineered. 2016; 7(6):478-483.

PMID: 27566060 PMC: 5241812. DOI: 10.1080/21655979.2016.1201252.


Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.

Mizanur R, Stafford R, Ahmed S PLoS One. 2014; 9(4):e95188.

PMID: 24769566 PMC: 4000213. DOI: 10.1371/journal.pone.0095188.


The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.

Silhar P, Lardy M, Hixon M, Shoemaker C, Barbieri J, Struss A ACS Med Chem Lett. 2013; 4(2):283-287.

PMID: 23565325 PMC: 3615567. DOI: 10.1021/ml300428s.


References
1.
Ahmed S, McPhie P, Smith L . Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active. Biochemistry. 2003; 42(43):12539-49. DOI: 10.1021/bi030062c. View

2.
DasGupta B, Antharavally B, Tepp W, Evenson M . Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins. Protein J. 2005; 24(6):337-68. DOI: 10.1007/s10930-005-7589-z. View

3.
Xu J, Deng Q, Chen J, Houk K, Bartek J, Hilvert D . Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Science. 1999; 286(5448):2345-8. DOI: 10.1126/science.286.5448.2345. View

4.
Fischer A, Mushrush D, Lacy D, Montal M . Botulinum neurotoxin devoid of receptor binding domain translocates active protease. PLoS Pathog. 2008; 4(12):e1000245. PMC: 2596314. DOI: 10.1371/journal.ppat.1000245. View

5.
Ahmed S, Ludivico M, Smith L . Factors affecting autocatalysis of botulinum A neurotoxin light chain. Protein J. 2005; 23(7):445-51. DOI: 10.1007/s10930-004-5220-3. View